APACHE II

New Relic Pioneers Business Observability with Pathpoint

Retrieved on: 
수요일, 1월 24, 2024
Engineering, Data Management, Technology, Manufacturing, Software, Internet, APM, Organization, Churn, APACHE II, ROI, Risk management

New Relic , the all-in-one observability platform for every engineer, announced New Relic Pathpoint , a business observability solution designed to bridge the data gap between IT and real-world business outcomes.

Key Points: 
  • New Relic , the all-in-one observability platform for every engineer, announced New Relic Pathpoint , a business observability solution designed to bridge the data gap between IT and real-world business outcomes.
  • Pathpoint helps engineering and IT teams drive operational efficiency, analyze the financial impact of issues, and align service performance to business outcomes.
  • Pathpoint allows engineers to alert both technical and business teams in near-real time if there is an unwanted change in their business metrics.
  • Pathpoint is also instrumental in helping technical teams provide their business counterparts with visibility into critical metrics that directly impact the business, such as revenue lost during an outage.

OpenTitan® Partnership Announces First Public Secure Execution Environment for Integrated

Retrieved on: 
월요일, 11월 13, 2023
Devrient, Socs, Organization, Giesecke, Ecosystem, Documentation, SOC, Rot, APACHE II, Partnership, LowRISC, Growth, Architecture, Renewable energy, Winbond, Silicon

, the open silicon ecosystem organization, and zeroRISC , the first provider of commercial cloud security services for open silicon, today announced the early release of the first SoC secure execution environment, including root of trust (RoT) functionality, as part of the OpenTitan project.

Key Points: 
  • , the open silicon ecosystem organization, and zeroRISC , the first provider of commercial cloud security services for open silicon, today announced the early release of the first SoC secure execution environment, including root of trust (RoT) functionality, as part of the OpenTitan project.
  • Since 2018, the OpenTitan coalition has been focused on creating an open silicon ecosystem by consistently following a well-defined roadmap from discrete to integrated secure silicon designs.
  • While developing the architecture and specifications for the integrated secure execution environment, the project also accomplished the first discrete silicon tapeout in June 2023, a critical precursor to commercial silicon availability in 2024.
  • As more businesses embrace the project, the open and collaborative spirit of OpenTitan will continue to foster innovation and drive advancements in secure hardware design.

Mattermost Introduces “OpenOps” to Speed Responsible Evaluation of Generative AI Applied to Workflows

Retrieved on: 
수요일, 6월 28, 2023
Graphics processing unit, Mattermost, LLM, Microsoft Teams, Collection, AIS, APACHE II, PALO, Safety, Interchangeability, Synthetic media, Microsoft, Research, Hugging Face, MIT, OpenAI, IP, Architecture, Apache, App Store (iOS/iPadOS), Free and open-source software, Organization, Falcon, Production, Risk, Learning, Generative, AI, Azure, Question, Environment, Conference, Automation, Medical device, Online shopping, Customer service, Trust

PALO ALTO, Calif., June 28, 2023 (GLOBE NEWSWIRE) -- At the 2023 Collision Conference, Mattermost, Inc., the secure collaboration platform for technical teams, announced the launch of “OpenOps”, an open-source approach to accelerating the responsible evaluation of AI-enhanced workflows and usage policies while maintaining data control and avoiding vendor lock-in.

Key Points: 
  • AI Bots with Interchangeable AI Backends: OpenOps enables AI bots to be integrated into operations while connected to an interchangeable array of AI platforms.
  • For maximum performance, tap into third-party AI frameworking including OpenAI ChatGPT, the Azure AI Platform and Anthropic Claude.
  • This allows organizations to develop a rich corpus of real-world training data for future AI backend evaluation and fine-tuning.
  • The system also removes the need for specialized hardware such as GPUs, broadening the number of developers who can explore self-hosted AI models.

HiveMQ Adds C# Client to Open-Source MQTT Client Libraries

Retrieved on: 
수요일, 4월 5, 2023
GitHub, Ecosystem, MQTT, Microsoft, APACHE II, Java, Internet of things

LANDSHUT, Germany, April 5, 2023 /PRNewswire-PRWeb/ -- HiveMQ, a global leader in enterprise MQTT solutions, today added a C# Client to the open-source HiveMQ MQTT Client Libraries. The new client appeals to any organization building IoT applications using the Microsoft .NET framework, extending the MQTT ecosystem with a reliable, performant and fully-supported client.

Key Points: 
  • LANDSHUT, Germany, April 5, 2023 /PRNewswire-PRWeb/ -- HiveMQ , a global leader in enterprise MQTT solutions, today added a C# Client to the open-source HiveMQ MQTT Client Libraries .
  • The new client appeals to any organization building IoT applications using the Microsoft .NET framework, extending the MQTT ecosystem with a reliable, performant and fully-supported client.
  • All of the clients in the HiveMQ MQTT Client Libraries, including the popular HiveMQ MQTT Java Client , work with any MQTT broker to fast-track application development cycles and ensure long-term flexibility for IoT deployments.
  • The HiveMQ MQTT C# client is available on GitHub under the liberal Apache 2 license, and community feedback and public contributions are welcome.

ContraFect Provides Update from the Futility Analysis of the Phase 3 DISRUPT Study of Exebacase

Retrieved on: 
월요일, 12월 19, 2022
Drug of last resort, Infection, Peptide, Staphylococcus, Fosfomycin, SOC, Knee, Data monitoring committee, Risk, Daptomycin, APACHE II, MRSA, APACHE, Patient, Mortality, Safety, Campaign, DSMB, Data set, Subclinical infection, Diagnosis, COVID, Pharmaceutical industry, MD

All patients in the DISRUPT study have now been independently adjudicated and the study database has been locked.

Key Points: 
  • All patients in the DISRUPT study have now been independently adjudicated and the study database has been locked.
  • The Phase 3 DISRUPT study of exebacase is a randomized, double-blind, placebo-controlled clinical study conducted in the United States in 259 of the planned 348 patients with S. aureus bacteremia, including right-sided endocarditis.
  • Enrollment in the trial was stopped following a review of the pre-specified, interim futility analysis by the independent Data Safety Monitoring Board (DSMB).
  • The company is planning a virtual fireside chat in the first quarter of 2023 for an in-depth review and discussion of the DISRUPT study.